What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?

Gynecologic Oncology

Volumn 111, Issue 1, 2008, Pages 46-48

  Abu Rustum, Nadeem R ^a   Chi, Dennis S ^a   Leitao, Mario ^a   Oke, Eniola A ^a   Hensley, Martee L ^a   Alektiar, Kaled M ^a   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endometrial cancer; Lymph node metastasis; Paraaortic nodes; Recurrent endometrial cancer; Staging

Indexed keywords

ABDOMEN; ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER GRADING; CANCER LOCALIZATION; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; DISTANT METASTASIS; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; ILEUM; INGUINAL REGION; KIDNEY BLOOD VESSEL; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; METASTASIS; OMENTUM; PARAAORTIC LYMPH NODE; PATIENT SELECTION; PELVIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; RECURRENT CANCER; SOFT TISSUE; VAGINA;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; UNITED STATES;

EID: 52049086442     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.010     Document Type: Article

References (7)

1. Eggener S.E., Carver B.S., Sharp D.S., Motzer R.J., Bosl G.J., and Sheinfeld J. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J. Urol. 177 (2007) 937-942 [discussion 942-3]
2. Carver B.S., Shayegan B., Eggener S., Stasi J., Motzer R.J., Bosl G.J., et al. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J. Clin. Oncol. 25 (2007) 4365-4369
3. ACOG Practice Bulletin. Obstet. Gynecol. 106 (2005) 413-425
4. Cragun J.M., Havrilesky L.J., Calingaert B., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J. Clin. Oncol. 23 (2005) 3668-3675
5. Lutman C.V., Havrilesky L.J., Cragun J.M., et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol. Oncol. 102 (2006) 92-97
6. Chan J.K., Cheung M.K., Huh W.K., Osann K., Husain A., Teng N.N., et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107 8 (2006) 1823-1830
7. Abu-Rustum N.R., Iasonos A., Zhou Q., Oke E., Soslow R.A., Alektiar K.M., et al. Barakat, Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?. Am. J. Obstet. Gynecol. 198 4 (2008) 457.e1-457.e5 [discussion 457.e5-6]